{"protocolSection": {"identificationModule": {"nctId": "NCT03052517", "orgStudyIdInfo": {"id": "CQAW039A2315"}, "secondaryIdInfos": [{"id": "2016-001560-11", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment", "officialTitle": "A 2-treatment Period, Randomized, Placebo-controlled, Multicenter Parallel-group Study to Assess the Safety of QAW039 When Added to Existing Asthma Therapy in GINA Steps 3, 4 and 5 Patients With Uncontrolled Asthma."}, "statusModule": {"statusVerifiedDate": "2020-09", "overallStatus": "TERMINATED", "whyStopped": "Company Decision", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-03-21", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2020-02-19", "type": "ACTUAL"}, "completionDateStruct": {"date": "2020-03-16", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-01-23", "studyFirstSubmitQcDate": "2017-02-09", "studyFirstPostDateStruct": {"date": "2017-02-14", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2020-09-14", "resultsFirstSubmitQcDate": "2020-09-14", "resultsFirstPostDateStruct": {"date": "2020-10-12", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-09-14", "lastUpdatePostDateStruct": {"date": "2020-10-12", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "oversightModule": {"isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "This study was a 2-treatment period, randomized, multicenter parallel-group study. The overall purpose of this study was to provide long- term safety data for fevipiprant (QAW039) (Dose 1 and Dose 2), compared with placebo, when added to the Global Initiative for Asthma (GINA) steps 3, 4, and 5 standard-of-care (SoC) asthma therapy (GINA 2016), in patients with moderate-to- severe asthma.\n\nThe purpose of this study was to provide long-term safety data for QAW039 150 mg once daily and 450 mg once daily, compared with placebo, when added to GINA steps 3, 4, and 5 standard-of-care asthma therapy (GINA 2020) in adult and adolescent (\u226512 years) patients with moderate-to-severe asthma. The study included 2 cohorts of patients:\n\n1. Rollover patients who had completed any of the four Phase 3 pivotal efficacy studies with QAW039 (QAW039A2307, QAW039A2314, QAW039A2316, or QAW039A2317, hereafter referred to as Studies A2307, A2314, A2316, and A2317), thus providing data for a longer duration of exposure, and\n2. New patients who had not previously participated in a study of QAW039, permitting an increase in the number of patients with long-term exposure to QAW039.\n\nBy including these 2 categories of patients, the total number of patients treated with QAW039 as well as the duration of exposure to QAW039 treatment was substantially increased, supporting evaluation of the safety profile of QAW039.", "detailedDescription": "The study comprised 2-treatment period. Treatment Period 1 was a 52-week, double-blind treatment period in which QAW039 450 mg or 150 mg or placebo was added to standard-of-care asthma therapy according to GINA guidelines. Treatment Period 2 was an optional 104-week, single-blind treatment period in which patients received QAW039 450 mg or 150 mg or placebo added to standard-of-care asthma therapy according to GINA guidelines."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma", "QAW039", "allergic asthma", "allergy triggered asthma", "reactive asthma", "asthma attack", "difficulty breathing"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 2538, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "QAW039 150mg", "type": "EXPERIMENTAL", "description": "QAW039 Dose 1 once daily", "interventionNames": ["Drug: QAW039 150 mg"]}, {"label": "QAW039 450 mg", "type": "EXPERIMENTAL", "description": "QAW039 Dose 2 once daily", "interventionNames": ["Drug: QAW039 450 mg"]}, {"label": "Placebo", "type": "PLACEBO_COMPARATOR", "description": "Placebo once daily", "interventionNames": ["Drug: Placebo"]}], "interventions": [{"type": "DRUG", "name": "QAW039 150 mg", "description": "One tablet of QAW039 150 mg once daily", "armGroupLabels": ["QAW039 150mg"]}, {"type": "DRUG", "name": "QAW039 450 mg", "description": "One tablet of QAW039 450 mg once daily", "armGroupLabels": ["QAW039 450 mg"]}, {"type": "DRUG", "name": "Placebo", "description": "One tablet of Placebo once daily", "armGroupLabels": ["Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 52 - Cox Regression Model", "description": "Adverse events starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE) were classified as treatment emergent AEs. For this Outcome Measure, AE up to week 52 are reported.", "timeFrame": "52 weeks"}, {"measure": "Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 156 - Cox Regression Model", "description": "Adverse events starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE) were classified as treatment emergent AEs", "timeFrame": "156 weeks"}, {"measure": "Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 52 - Cox Regression Model", "description": "Serious Adverse events starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +30 days were classified as treatment emergent SAEs. For this Outcome Measure, AE up to week 52 are reported.", "timeFrame": "52 weeks"}, {"measure": "Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 156 - Cox Regression Model", "description": "Serious Adverse events starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +30 days were classified as treatment emergent SAEs.", "timeFrame": "156 weeks"}, {"measure": "Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 52 - Cox Regression Model", "description": "Adverse events leading to study treatment discontinuation starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE) were classified as treatment emergent AEs leading to study treatment discontinuation. For this Outcome Measure, AE up to week 52 are reported.", "timeFrame": "52 weeks"}, {"measure": "Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 156 - Cox Regression Model", "description": "Adverse events leading to study treatment discontinuation starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE) were classified as treatment emergent AEs leading to study treatment discontinuation", "timeFrame": "156 weeks"}], "secondaryOutcomes": [{"measure": "Number of Patients With at Least One Treatment Emergent AE by Primary System Organ Class up to Week 52 - Logistic Regression Model", "description": "The number of patients per patient year of follow-up having a treatment emergent adverse event, categorized by system organ class. Treatment emergent adverse events are defined as an AEs starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE)", "timeFrame": "52 weeks"}, {"measure": "Number of Patients With at Least One Treatment Emergent AE by Primary System Organ Class up to Week 156 - Logistic Regression Model", "description": "The number of patients per patient year of follow-up having a treatment emergent adverse event, categorized by system organ class. Treatment emergent adverse events are defined as an AEs starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE)", "timeFrame": "156 weeks"}, {"measure": "Number of Treatment Emergent Patient Deaths Due to an Asthma Exacerbation up to Week 52", "description": "The number of treatment emergent patient deaths due to an asthma exacerbation. Treatment emergent deaths are defined as deaths resulting from treatment emergent AEs.", "timeFrame": "52 weeks"}, {"measure": "Number of Treatment Emergent Patient Deaths Due to an Asthma Exacerbation up to Week 156", "description": "The number of treatment emergent patient deaths due to an asthma exacerbation. Treatment emergent deaths are defined as deaths resulting from treatment emergent AEs.", "timeFrame": "156 weeks"}, {"measure": "Rate of Treatment Emergent Severe Asthma Exacerbation Episodes Requiring Hospitalizations Per Person Year up to Week 52", "description": "Number of treatment emergent severe asthma exacerbation episodes requiring hospitalizations (any visit to the hospital requiring an overnight stay or an emergency room visit greater than 24 hours) per person year of follow-up. Treatment emergent severe asthma exacerbation episodes are defined as episodes occurring on or after the day of the first intake of study drug and until the day of last intake of study drug +7 days (30 days in the case of a serious AE).\n\nRate of exacerbations per person year = total number of exacerbations / total number of treatment years", "timeFrame": "52 weeks"}, {"measure": "Rate of Treatment Emergent Severe Asthma Exacerbation Episodes Requiring Hospitalizations Per Person Year up to Week 156", "description": "Number of treatment emergent severe asthma exacerbation episodes requiring hospitalizations (any visit to the hospital requiring an overnight stay or an emergency room visit greater than 24 hours) per person year of follow-up. Treatment emergent severe asthma exacerbation episodes are defined as episodes occurring on or after the day of the first intake of study drug and until the day of last intake of study drug +7 days (30 days in the case of a serious AE).\n\nRate of exacerbations per person year = total number of exacerbations / total number of treatment years", "timeFrame": "156 weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\nPatients completing a prior Phase 3 study of QAW039:\n\n* Informed consent and assent (if applicable).\n* Completion of the Treatment Period (on blinded study drug) of a prior Phase 3 study of QAW039.\n* Patient is able to safely continue into the study as judged by the investigator.\n\nPatients who have not previously participated in a study of QAW039:\n\n* Written informed consent.\n* A diagnosis of asthma,uncontrolled on GINA 3/4/5 asthma medication.\n* Evidence of airway reversibility or airway hyper- reactivity.\n* FEV1 of \u226485% of the predicted normal value.\n* An ACQ score \u22651.5 prior to entering the study.\n\nExclusion Criteria:\n\nPatients completing a prior phase 3 study of QAW039:\n\n* Pregnant or nursing (lactating) women.\n* Women of child-bearing potential unless they are using basic methods of contraception during dosing of study drug\n* Patients who did not complete the Treatment Period on blinded study drug of the prior QAW039 study they participated in.\n* Inability to comply with all study requirements.\n* Patient who experienced a serious and drug-related AE in the prior QAW039 study they participated in.\n\nPatients who have not previously participated in a study of QAW039:\n\n* Use of other investigational drugs within 5 half-lives of study entry, or within 30 days, whichever is longer.\n* Subjects who have participated in another trial of QAW039 (i.e.-the patient was randomized in another study).\n* A QTcF (Fridericia) \u2265450 msec (male) or \u2265460 msec (female).\n* History of malignancy with the exception of local basal cell carcinoma of the skin\n* Pregnant or nursing (lactating) women.\n* Serious co-morbidities.\n* Patients on greater than 20 mg of simvastatin\\> 40 mg of atorvastatin, \\>40 mg of pravastatin, or \\>2 mg of pitavastatin. Statin doses less than or equal to these doses as well as other statins will be permitted during the study.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "12 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Novartis Pharmaceuticals Novartis Pharmaceuticals", "affiliation": "Novartis Pharmaceuticals", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Novartis Investigative Site", "city": "Birmingham", "state": "Alabama", "zip": "35209", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Novartis Investigative Site", "city": "Encinitas", "state": "California", "zip": "92024", "country": "United States", "geoPoint": {"lat": 33.03699, "lon": -117.29198}}, {"facility": "Novartis Investigative Site", "city": "Newport Beach", "state": "California", "zip": "92663", "country": "United States", "geoPoint": {"lat": 33.61891, "lon": -117.92895}}, {"facility": "Novartis Investigative Site", "city": "Orange", "state": "California", "zip": "92868", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -117.85311}}, {"facility": "Novartis Investigative Site", "city": "San Diego", "state": "California", "zip": "92117", "country": "United States", "geoPoint": {"lat": 32.71533, "lon": -117.15726}}, {"facility": "Novartis Investigative Site", "city": "Stockton", "state": "California", "zip": "95207", "country": "United States", "geoPoint": {"lat": 37.9577, "lon": -121.29078}}, {"facility": "Novartis Investigative Site", "city": "Walnut Creek", "state": "California", "zip": "94598", "country": "United States", "geoPoint": {"lat": 37.90631, "lon": -122.06496}}, {"facility": "Novartis Investigative Site", "city": "Westminster", "state": "California", "zip": "92683", "country": "United States", "geoPoint": {"lat": 33.75918, "lon": -118.00673}}, {"facility": "Novartis Investigative Site", "city": "Colorado Springs", "state": "Colorado", "zip": "80907", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "Novartis Investigative Site", "city": "Denver", "state": "Colorado", "zip": "80230", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "Novartis Investigative Site", "city": "Lafayette", "state": "Colorado", "zip": "80026", "country": "United States", "geoPoint": {"lat": 39.9936, "lon": -105.08971}}, {"facility": "Novartis Investigative Site", "city": "Miami", "state": "Florida", "zip": "33176", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "Novartis Investigative Site", "city": "Tamarac", "state": "Florida", "zip": "33321", "country": "United States", "geoPoint": {"lat": 26.21286, "lon": -80.24977}}, {"facility": "Novartis Investigative Site", "city": "Winter Park", "state": "Florida", "zip": "32789", "country": "United States", "geoPoint": {"lat": 28.6, "lon": -81.33924}}, {"facility": "Novartis Investigative Site", "city": "Marietta", "state": "Georgia", "zip": "30060", "country": "United States", "geoPoint": {"lat": 33.9526, "lon": -84.54993}}, {"facility": "Novartis Investigative Site", "city": "Overland Park", "state": "Kansas", "zip": "66210", "country": "United States", "geoPoint": {"lat": 38.98223, "lon": -94.67079}}, {"facility": "Novartis Investigative Site", "city": "Louisville", "state": "Kentucky", "zip": "40215", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"facility": "Novartis Investigative Site", "city": "Zachary", "state": "Louisiana", "zip": "70791", "country": "United States", "geoPoint": {"lat": 30.64852, "lon": -91.1565}}, {"facility": "Novartis Investigative Site", "city": "Bangor", "state": "Maine", "zip": "04401", "country": "United States", "geoPoint": {"lat": 44.80118, "lon": -68.77781}}, {"facility": "Novartis Investigative Site", "city": "Columbia", "state": "Maryland", "zip": "21044", "country": "United States", "geoPoint": {"lat": 39.24038, "lon": -76.83942}}, {"facility": "Novartis Investigative Site", "city": "Waldorf", "state": "Maryland", "zip": "20602", "country": "United States", "geoPoint": {"lat": 38.62456, "lon": -76.93914}}, {"facility": "Novartis Investigative Site", "city": "Ypsilanti", "state": "Michigan", "zip": "48197", "country": "United States", "geoPoint": {"lat": 42.24115, "lon": -83.61299}}, {"facility": "Novartis Investigative Site", "city": "Missoula", "state": "Montana", "zip": "59804", "country": "United States", "geoPoint": {"lat": 46.87215, "lon": -113.994}}, {"facility": "Novartis Investigative Site", "city": "Bellevue", "state": "Nebraska", "zip": "68123", "country": "United States", "geoPoint": {"lat": 41.13667, "lon": -95.89084}}, {"facility": "Novartis Investigative Site", "city": "La Vista", "state": "Nebraska", "zip": "68128", "country": "United States", "geoPoint": {"lat": 41.18389, "lon": -96.03113}}, {"facility": "Novartis Investigative Site", "city": "Omaha", "state": "Nebraska", "zip": "68131", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "Novartis Investigative Site", "city": "Omaha", "state": "Nebraska", "zip": "68134", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "Novartis Investigative Site", "city": "Bronx", "state": "New York", "zip": "10459", "country": "United States", "geoPoint": {"lat": 40.84985, "lon": -73.86641}}, {"facility": "Novartis Investigative Site", "city": "Asheville", "state": "North Carolina", "zip": "28801", "country": "United States", "geoPoint": {"lat": 35.60095, "lon": -82.55402}}, {"facility": "Novartis Investigative Site", "city": "Gastonia", "state": "North Carolina", "zip": "28054", "country": "United States", "geoPoint": {"lat": 35.26208, "lon": -81.1873}}, {"facility": "Novartis Investigative Site", "city": "Columbus", "state": "Ohio", "zip": "43215", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "Novartis Investigative Site", "city": "Edmond", "state": "Oklahoma", "zip": "73034", "country": "United States", "geoPoint": {"lat": 35.65283, "lon": -97.4781}}, {"facility": "Novartis Investigative Site", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73120", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "Novartis Investigative Site", "city": "Medford", "state": "Oregon", "zip": "97504", "country": "United States", "geoPoint": {"lat": 42.32652, "lon": -122.87559}}, {"facility": "Novartis Investigative Site", "city": "Altoona", "state": "Pennsylvania", "zip": "16602", "country": "United States", "geoPoint": {"lat": 40.51868, "lon": -78.39474}}, {"facility": "Novartis Investigative Site", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15221", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Novartis Investigative Site", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15241", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Novartis Investigative Site", "city": "East Providence", "state": "Rhode Island", "zip": "02941", "country": "United States", "geoPoint": {"lat": 41.81371, "lon": -71.37005}}, {"facility": "Novartis Investigative Site", "city": "Boerne", "state": "Texas", "zip": "78006", "country": "United States", "geoPoint": {"lat": 29.79466, "lon": -98.73197}}, {"facility": "Novartis Investigative Site", "city": "Fort Worth", "state": "Texas", "zip": "76244", "country": "United States", "geoPoint": {"lat": 32.72541, "lon": -97.32085}}, {"facility": "Novartis Investigative Site", "city": "McKinney", "state": "Texas", "zip": "75069", "country": "United States", "geoPoint": {"lat": 33.19762, "lon": -96.61527}}, {"facility": "Novartis Investigative Site", "city": "Plano", "state": "Texas", "zip": "75093", "country": "United States", "geoPoint": {"lat": 33.01984, "lon": -96.69889}}, {"facility": "Novartis Investigative Site", "city": "San Antonio", "state": "Texas", "zip": "78205", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "Novartis Investigative Site", "city": "Richmond", "state": "Virginia", "zip": "23225", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "Novartis Investigative Site", "city": "Bellingham", "state": "Washington", "zip": "98225", "country": "United States", "geoPoint": {"lat": 48.75955, "lon": -122.48822}}, {"facility": "Novartis Investigative Site", "city": "Spokane", "state": "Washington", "zip": "99204", "country": "United States", "geoPoint": {"lat": 47.65966, "lon": -117.42908}}, {"facility": "Novartis Investigative Site", "city": "Berazategui", "state": "Buenos Aires", "zip": "1888", "country": "Argentina", "geoPoint": {"lat": -34.76531, "lon": -58.21278}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1056ABJ", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1122AAK", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1425BEN", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1426ABP", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Lanus", "state": "Buenos Aires", "zip": "B8000XAV", "country": "Argentina", "geoPoint": {"lat": -34.70252, "lon": -58.3955}}, {"facility": "Novartis Investigative Site", "city": "Mar del Plata", "state": "Buenos Aires", "zip": "7600", "country": "Argentina", "geoPoint": {"lat": -38.00228, "lon": -57.55754}}, {"facility": "Novartis Investigative Site", "city": "Ranelagh, Partido De Berazate", "state": "Buenos Aires", "zip": "1884", "country": "Argentina"}, {"facility": "Novartis Investigative Site", "city": "Santa Rosa", "state": "La Pampa", "zip": "6300", "country": "Argentina", "geoPoint": {"lat": -36.61667, "lon": -64.28333}}, {"facility": "Novartis Investigative Site", "city": "Santa Fe", "state": "Rosario", "zip": "S2000DBS", "country": "Argentina", "geoPoint": {"lat": -31.63333, "lon": -60.7}}, {"facility": "Novartis Investigative Site", "city": "Rosario", "state": "Santa Fe", "zip": "S2000AII", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Novartis Investigative Site", "city": "Rosario", "state": "Santa Fe", "zip": "S2000BRH", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Novartis Investigative Site", "city": "Rosario", "state": "Santa Fe", "zip": "S2000JKR", "country": "Argentina", "geoPoint": {"lat": -32.94682, "lon": -60.63932}}, {"facility": "Novartis Investigative Site", "city": "San Miguel de Tucuman", "state": "Tucuman", "zip": "4000", "country": "Argentina", "geoPoint": {"lat": -26.82414, "lon": -65.2226}}, {"facility": "Novartis Investigative Site", "city": "San Miguel de Tucuman", "state": "Tucuman", "zip": "T4000IFL", "country": "Argentina", "geoPoint": {"lat": -26.82414, "lon": -65.2226}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1012AAR", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1125ABE", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1425FVH", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Cordoba", "zip": "X5003DCE", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Novartis Investigative Site", "city": "Mendoza", "zip": "5500", "country": "Argentina", "geoPoint": {"lat": -32.89084, "lon": -68.82717}}, {"facility": "Novartis Investigative Site", "city": "Mendoza", "zip": "M5500CBA", "country": "Argentina", "geoPoint": {"lat": -32.89084, "lon": -68.82717}}, {"facility": "Novartis Investigative Site", "city": "Salta", "zip": "4000", "country": "Argentina", "geoPoint": {"lat": -24.7859, "lon": -65.41166}}, {"facility": "Novartis Investigative Site", "city": "Santa Fe", "zip": "S3000FIL", "country": "Argentina", "geoPoint": {"lat": -31.63333, "lon": -60.7}}, {"facility": "Novartis Investigative Site", "city": "Clayton", "state": "Victoria", "zip": "3168", "country": "Australia", "geoPoint": {"lat": -37.91667, "lon": 145.11667}}, {"facility": "Novartis Investigative Site", "city": "Footscray", "state": "Victoria", "zip": "3011", "country": "Australia", "geoPoint": {"lat": -37.8, "lon": 144.9}}, {"facility": "Novartis Investigative Site", "city": "Melbourne", "state": "Victoria", "zip": "3004", "country": "Australia", "geoPoint": {"lat": -37.814, "lon": 144.96332}}, {"facility": "Novartis Investigative Site", "city": "Feldkirch", "zip": "6800", "country": "Austria", "geoPoint": {"lat": 47.23306, "lon": 9.6}}, {"facility": "Novartis Investigative Site", "city": "Vienna", "zip": "A-1130", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"facility": "Novartis Investigative Site", "city": "Wien", "zip": "A 1090", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"facility": "Novartis Investigative Site", "city": "Aalst", "zip": "9300", "country": "Belgium", "geoPoint": {"lat": 50.93604, "lon": 4.0355}}, {"facility": "Novartis Investigative Site", "city": "Brussel", "zip": "1020", "country": "Belgium", "geoPoint": {"lat": 50.85045, "lon": 4.34878}}, {"facility": "Novartis Investigative Site", "city": "Bruxelles", "zip": "1000", "country": "Belgium", "geoPoint": {"lat": 50.85045, "lon": 4.34878}}, {"facility": "Novartis Investigative Site", "city": "Eghezee", "zip": "5310", "country": "Belgium", "geoPoint": {"lat": 50.59076, "lon": 4.91175}}, {"facility": "Novartis Investigative Site", "city": "Erpent", "zip": "5100", "country": "Belgium", "geoPoint": {"lat": 50.45116, "lon": 4.90557}}, {"facility": "Novartis Investigative Site", "city": "Herentals", "zip": "2200", "country": "Belgium", "geoPoint": {"lat": 51.17655, "lon": 4.83248}}, {"facility": "Novartis Investigative Site", "city": "Kortrijk", "zip": "8500", "country": "Belgium", "geoPoint": {"lat": 50.82803, "lon": 3.26487}}, {"facility": "Novartis Investigative Site", "city": "Liege", "zip": "4000", "country": "Belgium", "geoPoint": {"lat": 50.63373, "lon": 5.56749}}, {"facility": "Novartis Investigative Site", "city": "Goiania", "state": "GO", "zip": "74110-030", "country": "Brazil", "geoPoint": {"lat": -16.67861, "lon": -49.25389}}, {"facility": "Novartis Investigative Site", "city": "Porto Alegre", "state": "Porto Alegre RS", "zip": "90610 000", "country": "Brazil", "geoPoint": {"lat": -30.03306, "lon": -51.23}}, {"facility": "Novartis Investigative Site", "city": "Rio de Janeiro", "state": "RJ", "zip": "21941-590", "country": "Brazil", "geoPoint": {"lat": -22.90278, "lon": -43.2075}}, {"facility": "Novartis Investigative Site", "city": "Porto Alegre", "state": "RS", "zip": "90020-090", "country": "Brazil", "geoPoint": {"lat": -30.03306, "lon": -51.23}}, {"facility": "Novartis Investigative Site", "city": "Blumenau", "state": "Santa Catarina", "zip": "89030101", "country": "Brazil", "geoPoint": {"lat": -26.91944, "lon": -49.06611}}, {"facility": "Novartis Investigative Site", "city": "Sao Bernardo do Campo", "state": "SP", "zip": "09715 090", "country": "Brazil", "geoPoint": {"lat": -23.69389, "lon": -46.565}}, {"facility": "Novartis Investigative Site", "city": "Sao Paulo", "state": "SP", "zip": "05403 000", "country": "Brazil", "geoPoint": {"lat": -23.5475, "lon": -46.63611}}, {"facility": "Novartis Investigative Site", "city": "Sao Paulo", "state": "SP", "zip": "05437 010", "country": "Brazil", "geoPoint": {"lat": -23.5475, "lon": -46.63611}}, {"facility": "Novartis Investigative Site", "city": "Sorocaba", "state": "SP", "country": "Brazil", "geoPoint": {"lat": -23.50167, "lon": -47.45806}}, {"facility": "Novartis Investigative Site", "city": "Pleven", "zip": "5800", "country": "Bulgaria", "geoPoint": {"lat": 43.41667, "lon": 24.61667}}, {"facility": "Novartis Investigative Site", "city": "Ruse", "zip": "7002", "country": "Bulgaria", "geoPoint": {"lat": 43.85639, "lon": 25.97083}}, {"facility": "Novartis Investigative Site", "city": "Sofia", "zip": "1000", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "Novartis Investigative Site", "city": "Stara Zagora", "zip": "6000", "country": "Bulgaria", "geoPoint": {"lat": 42.43278, "lon": 25.64194}}, {"facility": "Novartis Investigative Site", "city": "Vancouver", "state": "British Columbia", "zip": "V6Z 1Y6", "country": "Canada", "geoPoint": {"lat": 49.24966, "lon": -123.11934}}, {"facility": "Novartis Investigative Site", "city": "Toronto", "state": "Ontario", "zip": "M6H 3M2", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "Novartis Investigative Site", "city": "Toronto", "state": "Ontario", "zip": "M9V 4B4", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "Novartis Investigative Site", "city": "Windsor", "state": "Ontario", "zip": "N8X 5A6", "country": "Canada", "geoPoint": {"lat": 42.30008, "lon": -83.01654}}, {"facility": "Novartis Investigative Site", "city": "Montreal", "state": "Quebec", "zip": "H3G 1L5", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "Novartis Investigative Site", "city": "Montreal", "state": "Quebec", "zip": "H3T 1E2", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "Novartis Investigative Site", "city": "Montreal", "state": "Quebec", "zip": "H4J 1C5", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"facility": "Novartis Investigative Site", "city": "Quebec", "zip": "G1V 4W2", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}, {"facility": "Novartis Investigative Site", "city": "Vancouver", "country": "Canada", "geoPoint": {"lat": 49.24966, "lon": -123.11934}}, {"facility": "Novartis Investigative Site", "city": "Guang Zhou", "state": "Guang Dong Province", "zip": "510120", "country": "China"}, {"facility": "Novartis Investigative Site", "city": "Shijiazhuang", "state": "Hebei", "zip": "050000", "country": "China", "geoPoint": {"lat": 38.04139, "lon": 114.47861}}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "state": "Jiangsu", "zip": "210006", "country": "China", "geoPoint": {"lat": 32.06167, "lon": 118.77778}}, {"facility": "Novartis Investigative Site", "city": "Nanjing", "state": "Jiangsu", "zip": "210009", "country": "China", "geoPoint": {"lat": 32.06167, "lon": 118.77778}}, {"facility": "Novartis Investigative Site", "city": "Chang Chun", "state": "Jilin", "zip": "130021", "country": "China", "geoPoint": {"lat": 42.74694, "lon": 126.24667}}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "state": "Liaoning", "zip": "110000", "country": "China", "geoPoint": {"lat": 41.79222, "lon": 123.43278}}, {"facility": "Novartis Investigative Site", "city": "Shenyang", "state": "Liaoning", "zip": "110003", "country": "China", "geoPoint": {"lat": 41.79222, "lon": 123.43278}}, {"facility": "Novartis Investigative Site", "city": "Xian", "state": "Shanxi", "zip": "710061", "country": "China", "geoPoint": {"lat": 34.25833, "lon": 108.92861}}, {"facility": "Novartis Investigative Site", "city": "Chengdu", "state": "Sichuan", "zip": "610041", "country": "China", "geoPoint": {"lat": 30.66667, "lon": 104.06667}}, {"facility": "Novartis Investigative Site", "city": "Beijing", "zip": "100050", "country": "China", "geoPoint": {"lat": 39.9075, "lon": 116.39723}}, {"facility": "Novartis Investigative Site", "city": "Chongqing", "zip": "400037", "country": "China", "geoPoint": {"lat": 29.56278, "lon": 106.55278}}, {"facility": "Novartis Investigative Site", "city": "Shanghai", "zip": "200433", "country": "China", "geoPoint": {"lat": 31.22222, "lon": 121.45806}}, {"facility": "Novartis Investigative Site", "city": "Ibague", "state": "Tolima", "zip": "730006", "country": "Colombia", "geoPoint": {"lat": 4.43889, "lon": -75.23222}}, {"facility": "Novartis Investigative Site", "city": "Bogota", "zip": "110221", "country": "Colombia", "geoPoint": {"lat": 4.60971, "lon": -74.08175}}, {"facility": "Novartis Investigative Site", "city": "Bucaramanga", "country": "Colombia", "geoPoint": {"lat": 7.12539, "lon": -73.1198}}, {"facility": "Novartis Investigative Site", "city": "Jindrichuv Hradec", "state": "Czech Republic", "zip": "377 01", "country": "Czechia", "geoPoint": {"lat": 49.14404, "lon": 15.00301}}, {"facility": "Novartis Investigative Site", "city": "Teplice", "state": "Czech Republic", "zip": "415 01", "country": "Czechia", "geoPoint": {"lat": 50.6404, "lon": 13.82451}}, {"facility": "Novartis Investigative Site", "city": "Teplice", "state": "CZE", "zip": "415 01", "country": "Czechia", "geoPoint": {"lat": 50.6404, "lon": 13.82451}}, {"facility": "Novartis Investigative Site", "city": "Brno", "zip": "615 00", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "Novartis Investigative Site", "city": "Karlovy Vary", "zip": "360 17", "country": "Czechia", "geoPoint": {"lat": 50.23271, "lon": 12.87117}}, {"facility": "Novartis Investigative Site", "city": "Mlada Boleslav", "zip": "293 50", "country": "Czechia", "geoPoint": {"lat": 50.41135, "lon": 14.90318}}, {"facility": "Novartis Investigative Site", "city": "Tallinn", "zip": "13419", "country": "Estonia", "geoPoint": {"lat": 59.43696, "lon": 24.75353}}, {"facility": "Novartis Investigative Site", "city": "Tartu", "zip": "51014", "country": "Estonia", "geoPoint": {"lat": 58.38062, "lon": 26.72509}}, {"facility": "Novartis Investigative Site", "city": "Helsinki", "zip": "00029", "country": "Finland", "geoPoint": {"lat": 60.16952, "lon": 24.93545}}, {"facility": "Novartis Investigative Site", "city": "Montpellier cedex 5", "state": "Herault", "zip": "34059", "country": "France", "geoPoint": {"lat": 43.61092, "lon": 3.87723}}, {"facility": "Novartis Investigative Site", "city": "Dijon", "zip": "21000", "country": "France", "geoPoint": {"lat": 47.31667, "lon": 5.01667}}, {"facility": "Novartis Investigative Site", "city": "Le Kremlin Bicetre", "zip": "94275", "country": "France", "geoPoint": {"lat": 48.81471, "lon": 2.36073}}, {"facility": "Novartis Investigative Site", "city": "Lyon Cedex 04", "zip": "69317", "country": "France", "geoPoint": {"lat": 45.74848, "lon": 4.84669}}, {"facility": "Novartis Investigative Site", "city": "Marseille", "zip": "13015", "country": "France", "geoPoint": {"lat": 43.29551, "lon": 5.38958}}, {"facility": "Novartis Investigative Site", "city": "Nantes", "zip": "44093", "country": "France", "geoPoint": {"lat": 47.21725, "lon": -1.55336}}, {"facility": "Novartis Investigative Site", "city": "Paris cedex 18", "zip": "75877", "country": "France", "geoPoint": {"lat": 48.85341, "lon": 2.3488}}, {"facility": "Novartis Investigative Site", "city": "Strasbourg Cedex", "zip": "67091", "country": "France", "geoPoint": {"lat": 48.58392, "lon": 7.74553}}, {"facility": "Novartis Investigative Site", "city": "Cottbus", "state": "Sachsen", "zip": "03050", "country": "Germany", "geoPoint": {"lat": 51.75769, "lon": 14.32888}}, {"facility": "Novartis Investigative Site", "city": "Aschaffenburg", "zip": "63739", "country": "Germany", "geoPoint": {"lat": 49.97704, "lon": 9.15214}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10717", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10969", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12159", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "12203", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Frankfurt", "zip": "60389", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Novartis Investigative Site", "city": "Frankfurt", "zip": "60596", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Novartis Investigative Site", "city": "Landsberg", "zip": "86899", "country": "Germany", "geoPoint": {"lat": 51.52698, "lon": 12.16076}}, {"facility": "Novartis Investigative Site", "city": "Leipzig", "zip": "04357", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Novartis Investigative Site", "city": "Witten", "zip": "58452", "country": "Germany", "geoPoint": {"lat": 51.44362, "lon": 7.35258}}, {"facility": "Novartis Investigative Site", "city": "Athens", "state": "GR", "zip": "115 25", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Novartis Investigative Site", "city": "Athens", "state": "GR", "zip": "115 27", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Novartis Investigative Site", "city": "Thessaloniki", "state": "GR", "zip": "570 10", "country": "Greece", "geoPoint": {"lat": 40.64361, "lon": 22.93086}}, {"facility": "Novartis Investigative Site", "city": "Athens", "zip": "115 21", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Novartis Investigative Site", "city": "Athens", "zip": "115 27", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Novartis Investigative Site", "city": "Athens", "zip": "175 62", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"facility": "Novartis Investigative Site", "city": "Gautemala City", "state": "Gautemala", "zip": "01010", "country": "Guatemala"}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "state": "GTM", "zip": "01010", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "state": "GTM", "zip": "01011", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "zip": "01010", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "zip": "01011", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Budaors", "state": "HUN", "zip": "2040", "country": "Hungary", "geoPoint": {"lat": 47.46181, "lon": 18.95845}}, {"facility": "Novartis Investigative Site", "city": "Gyor", "state": "HUN", "zip": "9024", "country": "Hungary", "geoPoint": {"lat": 47.68333, "lon": 17.63512}}, {"facility": "Novartis Investigative Site", "city": "Hajdunanas", "state": "HUN", "zip": "4080", "country": "Hungary", "geoPoint": {"lat": 47.85, "lon": 21.43333}}, {"facility": "Novartis Investigative Site", "city": "Puspokladany", "state": "HUN", "zip": "4150", "country": "Hungary", "geoPoint": {"lat": 47.31667, "lon": 21.11667}}, {"facility": "Novartis Investigative Site", "city": "Szazhalombatta", "state": "HUN", "zip": "2440", "country": "Hungary", "geoPoint": {"lat": 47.32579, "lon": 18.92141}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1106", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Godollo", "zip": "2100", "country": "Hungary", "geoPoint": {"lat": 47.59657, "lon": 19.35515}}, {"facility": "Novartis Investigative Site", "city": "Komarom", "zip": "2900", "country": "Hungary", "geoPoint": {"lat": 47.74318, "lon": 18.11913}}, {"facility": "Novartis Investigative Site", "city": "Mako", "zip": "6900", "country": "Hungary", "geoPoint": {"lat": 46.21667, "lon": 20.48333}}, {"facility": "Novartis Investigative Site", "city": "Pecs", "zip": "7635", "country": "Hungary", "geoPoint": {"lat": 46.08333, "lon": 18.23333}}, {"facility": "Novartis Investigative Site", "city": "Siofok", "zip": "8600", "country": "Hungary", "geoPoint": {"lat": 46.90413, "lon": 18.058}}, {"facility": "Novartis Investigative Site", "city": "Szeged", "zip": "6722", "country": "Hungary", "geoPoint": {"lat": 46.253, "lon": 20.14824}}, {"facility": "Novartis Investigative Site", "city": "Torokbalint", "zip": "2045", "country": "Hungary", "geoPoint": {"lat": 47.42931, "lon": 18.91356}}, {"facility": "Novartis Investigative Site", "city": "Ahmedabad", "state": "Gujarat", "zip": "380 060", "country": "India", "geoPoint": {"lat": 23.02579, "lon": 72.58727}}, {"facility": "Novartis Investigative Site", "city": "Vadodara", "state": "Gujarat", "zip": "390022", "country": "India", "geoPoint": {"lat": 22.29941, "lon": 73.20812}}, {"facility": "Novartis Investigative Site", "city": "Nagpur", "state": "Maharashtra", "zip": "440015", "country": "India", "geoPoint": {"lat": 21.14631, "lon": 79.08491}}, {"facility": "Novartis Investigative Site", "city": "Pune", "state": "Maharashtra", "zip": "411014", "country": "India", "geoPoint": {"lat": 18.51957, "lon": 73.85535}}, {"facility": "Novartis Investigative Site", "city": "Bikaner", "state": "Rajasthan", "zip": "334 001", "country": "India", "geoPoint": {"lat": 28.01762, "lon": 73.31495}}, {"facility": "Novartis Investigative Site", "city": "Jaipur", "state": "Rajasthan", "zip": "302039", "country": "India", "geoPoint": {"lat": 26.91962, "lon": 75.78781}}, {"facility": "Novartis Investigative Site", "city": "Coimbatore", "state": "Tamil Nadu", "zip": "641 045", "country": "India", "geoPoint": {"lat": 11.00555, "lon": 76.96612}}, {"facility": "Novartis Investigative Site", "city": "DehraDun", "state": "Uttarakhand", "zip": "248001", "country": "India", "geoPoint": {"lat": 30.32295, "lon": 78.03168}}, {"facility": "Novartis Investigative Site", "city": "Ashkelon", "zip": "78278", "country": "Israel", "geoPoint": {"lat": 31.66926, "lon": 34.57149}}, {"facility": "Novartis Investigative Site", "city": "Haifa", "zip": "310 9601", "country": "Israel", "geoPoint": {"lat": 32.81841, "lon": 34.9885}}, {"facility": "Novartis Investigative Site", "city": "Haifa", "zip": "3436212", "country": "Israel", "geoPoint": {"lat": 32.81841, "lon": 34.9885}}, {"facility": "Novartis Investigative Site", "city": "Jerusalem", "zip": "91031", "country": "Israel", "geoPoint": {"lat": 31.76904, "lon": 35.21633}}, {"facility": "Novartis Investigative Site", "city": "Jerusalem", "zip": "91120", "country": "Israel", "geoPoint": {"lat": 31.76904, "lon": 35.21633}}, {"facility": "Novartis Investigative Site", "city": "Petach Tikva", "zip": "49100", "country": "Israel", "geoPoint": {"lat": 32.08707, "lon": 34.88747}}, {"facility": "Novartis Investigative Site", "city": "Rehovot", "zip": "76100", "country": "Israel", "geoPoint": {"lat": 31.89421, "lon": 34.81199}}, {"facility": "Novartis Investigative Site", "city": "Nagoya", "state": "Aichi", "zip": "466 8560", "country": "Japan", "geoPoint": {"lat": 35.18147, "lon": 136.90641}}, {"facility": "Novartis Investigative Site", "city": "Matsuyama-city", "state": "Ehime", "zip": "790-0024", "country": "Japan", "geoPoint": {"lat": 33.83916, "lon": 132.76574}}, {"facility": "Novartis Investigative Site", "city": "Matsuyama-city", "state": "Ehime", "zip": "790-8524", "country": "Japan", "geoPoint": {"lat": 33.83916, "lon": 132.76574}}, {"facility": "Novartis Investigative Site", "city": "Chikushino-city", "state": "Fukuoka", "zip": "818-8502", "country": "Japan", "geoPoint": {"lat": 33.49631, "lon": 130.5156}}, {"facility": "Novartis Investigative Site", "city": "Fukuoka city", "state": "Fukuoka", "zip": "811-1394", "country": "Japan", "geoPoint": {"lat": 33.6, "lon": 130.41667}}, {"facility": "Novartis Investigative Site", "city": "Iizuka-city", "state": "Fukuoka", "zip": "820-8505", "country": "Japan", "geoPoint": {"lat": 33.63654, "lon": 130.68678}}, {"facility": "Novartis Investigative Site", "city": "Kasuga-city", "state": "Fukuoka", "zip": "816-0813", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Koga city", "state": "Fukuoka", "zip": "811 3195", "country": "Japan", "geoPoint": {"lat": 33.73333, "lon": 130.46667}}, {"facility": "Novartis Investigative Site", "city": "Yanagawa-city", "state": "Fukuoka", "zip": "832-0059", "country": "Japan", "geoPoint": {"lat": 33.16667, "lon": 130.4}}, {"facility": "Novartis Investigative Site", "city": "Mizunami-city", "state": "Gifu", "zip": "509 6134", "country": "Japan", "geoPoint": {"lat": 35.36667, "lon": 137.25}}, {"facility": "Novartis Investigative Site", "city": "Hiroshima-city", "state": "Hiroshima", "zip": "734-8530", "country": "Japan", "geoPoint": {"lat": 34.4, "lon": 132.45}}, {"facility": "Novartis Investigative Site", "city": "Sapporo", "state": "Hokkaido", "zip": "062-0931", "country": "Japan", "geoPoint": {"lat": 43.06667, "lon": 141.35}}, {"facility": "Novartis Investigative Site", "city": "Sapporo", "state": "Hokkaido", "zip": "064-0804", "country": "Japan", "geoPoint": {"lat": 43.06667, "lon": 141.35}}, {"facility": "Novartis Investigative Site", "city": "Himeji-city", "state": "Hyogo", "zip": "672-8064", "country": "Japan", "geoPoint": {"lat": 34.81667, "lon": 134.7}}, {"facility": "Novartis Investigative Site", "city": "Naka-gun", "state": "Ibaraki", "zip": "319-1113", "country": "Japan", "geoPoint": {"lat": 36.05, "lon": 140.16667}}, {"facility": "Novartis Investigative Site", "city": "Sakaide", "state": "Kagawa", "zip": "762-8550", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Takamatsu-city", "state": "Kagawa", "zip": "761-8073", "country": "Japan", "geoPoint": {"lat": 34.33333, "lon": 134.05}}, {"facility": "Novartis Investigative Site", "city": "Kagoshima city", "state": "Kagoshima", "zip": "890 8520", "country": "Japan", "geoPoint": {"lat": 31.56667, "lon": 130.55}}, {"facility": "Novartis Investigative Site", "city": "Sagamihara-city", "state": "Kanagawa", "zip": "228-8522", "country": "Japan", "geoPoint": {"lat": 35.54899, "lon": 139.26064}}, {"facility": "Novartis Investigative Site", "city": "Sagamihara-city", "state": "Kanagawa", "zip": "229-1103", "country": "Japan", "geoPoint": {"lat": 35.54899, "lon": 139.26064}}, {"facility": "Novartis Investigative Site", "city": "Yokohama city", "state": "Kanagawa", "zip": "232 0024", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Novartis Investigative Site", "city": "Yokohama-city", "state": "Kanagawa", "zip": "223-0059", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Novartis Investigative Site", "city": "Yokohama", "state": "Kanagawa", "zip": "234-0054", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"facility": "Novartis Investigative Site", "city": "Koshi-city", "state": "Kumamoto", "zip": "861-1196", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Matsusaka-city", "state": "Mie", "zip": "515-8544", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Tsu-city", "state": "Mie", "zip": "514-0125", "country": "Japan", "geoPoint": {"lat": 34.73333, "lon": 136.51667}}, {"facility": "Novartis Investigative Site", "city": "Sendai-city", "state": "Miyagi", "zip": "980-0871", "country": "Japan", "geoPoint": {"lat": 38.26667, "lon": 140.86667}}, {"facility": "Novartis Investigative Site", "city": "Sendai-city", "state": "Miyagi", "zip": "984-8560", "country": "Japan", "geoPoint": {"lat": 38.26667, "lon": 140.86667}}, {"facility": "Novartis Investigative Site", "city": "Kashihara city", "state": "Nara", "zip": "634 8522", "country": "Japan", "geoPoint": {"lat": 34.50896, "lon": 135.7929}}, {"facility": "Novartis Investigative Site", "city": "Habikino city", "state": "Osaka", "zip": "583 8588", "country": "Japan", "geoPoint": {"lat": 34.55276, "lon": 135.59097}}, {"facility": "Novartis Investigative Site", "city": "Kishiwada-city", "state": "Osaka", "zip": "596-8501", "country": "Japan", "geoPoint": {"lat": 34.46667, "lon": 135.36667}}, {"facility": "Novartis Investigative Site", "city": "Tokyo", "state": "Shibuya Ku", "zip": "150 0013", "country": "Japan", "geoPoint": {"lat": 35.6895, "lon": 139.69171}}, {"facility": "Novartis Investigative Site", "city": "Hamamatsu-city", "state": "Shizuoka", "zip": "431-3192", "country": "Japan", "geoPoint": {"lat": 34.7, "lon": 137.73333}}, {"facility": "Novartis Investigative Site", "city": "Chuo ku", "state": "Tokyo", "zip": "104-0031", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "Novartis Investigative Site", "city": "Chuo ku", "state": "Tokyo", "zip": "104-8560", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "Novartis Investigative Site", "city": "Chuo-ku", "state": "Tokyo", "zip": "103-0003", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "Novartis Investigative Site", "city": "Chuo-ku", "state": "Tokyo", "zip": "103-0028", "country": "Japan", "geoPoint": {"lat": 35.57779, "lon": 139.71685}}, {"facility": "Novartis Investigative Site", "city": "Itabashi-ku", "state": "Tokyo", "zip": "173-8610", "country": "Japan", "geoPoint": {"lat": 35.74893, "lon": 139.71497}}, {"facility": "Novartis Investigative Site", "city": "Kiyose-city", "state": "Tokyo", "zip": "204-8585", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Ota-ku", "state": "Tokyo", "zip": "145 0063", "country": "Japan", "geoPoint": {"lat": 36.3, "lon": 139.36667}}, {"facility": "Novartis Investigative Site", "city": "Setagaya-Ku", "state": "Tokyo", "zip": "157-0072", "country": "Japan", "geoPoint": {"lat": 35.64825, "lon": 139.65376}}, {"facility": "Novartis Investigative Site", "city": "Setagaya-ku", "state": "Tokyo", "zip": "157006", "country": "Japan", "geoPoint": {"lat": 35.64825, "lon": 139.65376}}, {"facility": "Novartis Investigative Site", "city": "Shinagawa-ku", "state": "Tokyo", "zip": "142-8666", "country": "Japan", "geoPoint": {"lat": 33.63627, "lon": 133.00572}}, {"facility": "Novartis Investigative Site", "city": "Shinjuku ku", "state": "Tokyo", "zip": "162 8655", "country": "Japan", "geoPoint": {"lat": 35.2946, "lon": 139.57059}}, {"facility": "Novartis Investigative Site", "city": "Shinjuku-ku", "state": "Tokyo", "zip": "169-0073", "country": "Japan", "geoPoint": {"lat": 35.2946, "lon": 139.57059}}, {"facility": "Novartis Investigative Site", "city": "Toshima ku", "state": "Tokyo", "zip": "170 0003", "country": "Japan"}, {"facility": "Novartis Investigative Site", "city": "Daugavpils", "zip": "LV-5401", "country": "Latvia", "geoPoint": {"lat": 55.88333, "lon": 26.53333}}, {"facility": "Novartis Investigative Site", "city": "Riga", "zip": "LV 1002", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "El Chouf", "state": "LBN", "zip": "1503201002", "country": "Lebanon"}, {"facility": "Novartis Investigative Site", "city": "Ashrafieh", "zip": "166830", "country": "Lebanon"}, {"facility": "Novartis Investigative Site", "city": "Beirut", "zip": "166378", "country": "Lebanon", "geoPoint": {"lat": 33.88894, "lon": 35.49442}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "state": "LTU", "zip": "LT 50161", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Vilnius", "state": "LTU", "zip": "LT-10207", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "state": "LT", "zip": "LT-45130", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "state": "LT", "zip": "LT-50128", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Klaipeda", "zip": "LT-92231", "country": "Lithuania", "geoPoint": {"lat": 55.70888, "lon": 21.14311}}, {"facility": "Novartis Investigative Site", "city": "Vilnius", "zip": "LT-04129", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"facility": "Novartis Investigative Site", "city": "Kota Bharu", "state": "Kelantan", "zip": "15586", "country": "Malaysia", "geoPoint": {"lat": 6.13328, "lon": 102.2386}}, {"facility": "Novartis Investigative Site", "city": "Kuantan", "state": "Pahang", "zip": "25100", "country": "Malaysia", "geoPoint": {"lat": 3.8077, "lon": 103.326}}, {"facility": "Novartis Investigative Site", "city": "Taiping", "state": "Perak", "zip": "34000", "country": "Malaysia", "geoPoint": {"lat": 4.85, "lon": 100.73333}}, {"facility": "Novartis Investigative Site", "city": "Guadalajara Jalisco", "state": "Jalisco", "zip": "44220", "country": "Mexico"}, {"facility": "Novartis Investigative Site", "city": "Guadalajara", "state": "Jalisco", "zip": "44130", "country": "Mexico", "geoPoint": {"lat": 20.66682, "lon": -103.39182}}, {"facility": "Novartis Investigative Site", "city": "Rio De Janeiro", "zip": "06700", "country": "Mexico", "geoPoint": {"lat": 16.11278, "lon": -91.5425}}, {"facility": "Novartis Investigative Site", "city": "Arnhem", "zip": "6815 AD", "country": "Netherlands", "geoPoint": {"lat": 51.98, "lon": 5.91111}}, {"facility": "Novartis Investigative Site", "city": "Leeuwarden", "zip": "8934 AD", "country": "Netherlands", "geoPoint": {"lat": 53.20139, "lon": 5.80859}}, {"facility": "Novartis Investigative Site", "city": "Cercado De Lima", "state": "Lima", "zip": "01", "country": "Peru"}, {"facility": "Novartis Investigative Site", "city": "San Isidro", "state": "Lima", "zip": "27", "country": "Peru", "geoPoint": {"lat": -12.11667, "lon": -77.05}}, {"facility": "Novartis Investigative Site", "city": "San Martin de Porres", "state": "Lima", "zip": "31", "country": "Peru"}, {"facility": "Novartis Investigative Site", "city": "Cusco", "zip": "84", "country": "Peru", "geoPoint": {"lat": -13.52264, "lon": -71.96734}}, {"facility": "Novartis Investigative Site", "city": "Lima", "zip": "1", "country": "Peru", "geoPoint": {"lat": -12.04318, "lon": -77.02824}}, {"facility": "Novartis Investigative Site", "city": "Piura", "zip": "2000", "country": "Peru", "geoPoint": {"lat": -5.19449, "lon": -80.63282}}, {"facility": "Novartis Investigative Site", "city": "Lipa City", "state": "Batangas", "zip": "4217", "country": "Philippines", "geoPoint": {"lat": 13.9411, "lon": 121.1631}}, {"facility": "Novartis Investigative Site", "city": "Quezon City", "state": "Manila", "zip": "1100", "country": "Philippines", "geoPoint": {"lat": 14.6488, "lon": 121.0509}}, {"facility": "Novartis Investigative Site", "city": "Bulacan", "zip": "3020", "country": "Philippines", "geoPoint": {"lat": 14.79278, "lon": 120.87889}}, {"facility": "Novartis Investigative Site", "city": "Iloilo City", "zip": "5000", "country": "Philippines", "geoPoint": {"lat": 10.69694, "lon": 122.56444}}, {"facility": "Novartis Investigative Site", "city": "Manila", "zip": "1000", "country": "Philippines", "geoPoint": {"lat": 14.6042, "lon": 120.9822}}, {"facility": "Novartis Investigative Site", "city": "Quezon City", "zip": "1100", "country": "Philippines", "geoPoint": {"lat": 14.6488, "lon": 121.0509}}, {"facility": "Novartis Investigative Site", "city": "Bialystok", "zip": "15-010", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Novartis Investigative Site", "city": "Kielce", "zip": "25-371", "country": "Poland", "geoPoint": {"lat": 50.87033, "lon": 20.62752}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "60-214", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "60-693", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "60-823", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Strzelce Opolskie", "zip": "47 100", "country": "Poland", "geoPoint": {"lat": 50.5107, "lon": 18.30056}}, {"facility": "Novartis Investigative Site", "city": "San Juan", "zip": "00909", "country": "Puerto Rico", "geoPoint": {"lat": 18.46633, "lon": -66.10572}}, {"facility": "Novartis Investigative Site", "city": "Bucharest", "state": "District 3", "zip": "030303", "country": "Romania", "geoPoint": {"lat": 44.43225, "lon": 26.10626}}, {"facility": "Novartis Investigative Site", "city": "Constanta", "state": "ROM", "zip": "900412", "country": "Romania", "geoPoint": {"lat": 44.18073, "lon": 28.63432}}, {"facility": "Novartis Investigative Site", "city": "Timisoara", "state": "Timis", "zip": "300310", "country": "Romania", "geoPoint": {"lat": 45.75372, "lon": 21.22571}}, {"facility": "Novartis Investigative Site", "city": "Bragadiru", "zip": "077025", "country": "Romania", "geoPoint": {"lat": 44.37111, "lon": 25.9775}}, {"facility": "Novartis Investigative Site", "city": "Brasov", "zip": "500051", "country": "Romania", "geoPoint": {"lat": 45.64861, "lon": 25.60613}}, {"facility": "Novartis Investigative Site", "city": "Brasov", "zip": "500086", "country": "Romania", "geoPoint": {"lat": 45.64861, "lon": 25.60613}}, {"facility": "Novartis Investigative Site", "city": "Brasov", "zip": "500283", "country": "Romania", "geoPoint": {"lat": 45.64861, "lon": 25.60613}}, {"facility": "Novartis Investigative Site", "city": "Brasov", "zip": "500366", "country": "Romania", "geoPoint": {"lat": 45.64861, "lon": 25.60613}}, {"facility": "Novartis Investigative Site", "city": "Cluj Napoca", "zip": "400139", "country": "Romania", "geoPoint": {"lat": 46.76667, "lon": 23.6}}, {"facility": "Novartis Investigative Site", "city": "Cluj-Napoca", "zip": "400371", "country": "Romania", "geoPoint": {"lat": 46.76667, "lon": 23.6}}, {"facility": "Novartis Investigative Site", "city": "Deva", "zip": "330162", "country": "Romania", "geoPoint": {"lat": 45.88333, "lon": 22.9}}, {"facility": "Novartis Investigative Site", "city": "Barnaul", "zip": "656024", "country": "Russian Federation", "geoPoint": {"lat": 53.36056, "lon": 83.76361}}, {"facility": "Novartis Investigative Site", "city": "Chelyabinsk", "zip": "454021", "country": "Russian Federation", "geoPoint": {"lat": 55.15402, "lon": 61.42915}}, {"facility": "Novartis Investigative Site", "city": "Izhevsk", "zip": "426061", "country": "Russian Federation", "geoPoint": {"lat": 56.84976, "lon": 53.20448}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "115478", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "125315", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "Nizhnii Novgorod", "zip": "603126", "country": "Russian Federation", "geoPoint": {"lat": 56.32867, "lon": 44.00205}}, {"facility": "Novartis Investigative Site", "city": "Penza", "zip": "440067", "country": "Russian Federation", "geoPoint": {"lat": 53.20066, "lon": 45.00464}}, {"facility": "Novartis Investigative Site", "city": "Perm", "zip": "614068", "country": "Russian Federation", "geoPoint": {"lat": 58.01046, "lon": 56.25017}}, {"facility": "Novartis Investigative Site", "city": "Ryazan", "zip": "390039", "country": "Russian Federation", "geoPoint": {"lat": 54.6269, "lon": 39.6916}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "194354", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint-Petersburg", "zip": "191186", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Sestroretsk", "zip": "197706", "country": "Russian Federation", "geoPoint": {"lat": 60.09801, "lon": 29.96378}}, {"facility": "Novartis Investigative Site", "city": "Smolensk", "country": "Russian Federation", "geoPoint": {"lat": 54.7818, "lon": 32.0401}}, {"facility": "Novartis Investigative Site", "city": "St Petersburg", "zip": "194354", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Stavropol", "zip": "355000", "country": "Russian Federation", "geoPoint": {"lat": 45.0428, "lon": 41.9734}}, {"facility": "Novartis Investigative Site", "city": "Yaroslavl", "zip": "150054", "country": "Russian Federation", "geoPoint": {"lat": 57.62987, "lon": 39.87368}}, {"facility": "Novartis Investigative Site", "city": "Yekaterinburg", "zip": "620109", "country": "Russian Federation", "geoPoint": {"lat": 56.8519, "lon": 60.6122}}, {"facility": "Novartis Investigative Site", "city": "Jeddah", "zip": "21423", "country": "Saudi Arabia", "geoPoint": {"lat": 21.54238, "lon": 39.19797}}, {"facility": "Novartis Investigative Site", "city": "Belgrade", "zip": "11000", "country": "Serbia", "geoPoint": {"lat": 44.80401, "lon": 20.46513}}, {"facility": "Novartis Investigative Site", "city": "Belgrade", "zip": "11070", "country": "Serbia", "geoPoint": {"lat": 44.80401, "lon": 20.46513}}, {"facility": "Novartis Investigative Site", "city": "Kragujevac", "zip": "34000", "country": "Serbia", "geoPoint": {"lat": 44.01667, "lon": 20.91667}}, {"facility": "Novartis Investigative Site", "city": "Nis", "zip": "18000", "country": "Serbia", "geoPoint": {"lat": 43.32472, "lon": 21.90333}}, {"facility": "Novartis Investigative Site", "city": "Sremska Kamenica", "zip": "21204", "country": "Serbia", "geoPoint": {"lat": 45.22158, "lon": 19.84367}}, {"facility": "Novartis Investigative Site", "city": "Singapore", "zip": "119228", "country": "Singapore", "geoPoint": {"lat": 1.28967, "lon": 103.85007}}, {"facility": "Novartis Investigative Site", "city": "Singapore", "zip": "529889", "country": "Singapore", "geoPoint": {"lat": 1.28967, "lon": 103.85007}}, {"facility": "Novartis Investigative Site", "city": "Bardejov", "state": "Slovak Republic", "zip": "085 01", "country": "Slovakia", "geoPoint": {"lat": 49.29175, "lon": 21.27271}}, {"facility": "Novartis Investigative Site", "city": "Bojnice", "state": "Slovak Republic", "zip": "972 01", "country": "Slovakia", "geoPoint": {"lat": 48.78511, "lon": 18.5864}}, {"facility": "Novartis Investigative Site", "city": "Kezmarok", "zip": "060 01", "country": "Slovakia", "geoPoint": {"lat": 49.13571, "lon": 20.43352}}, {"facility": "Novartis Investigative Site", "city": "Komarno", "zip": "945 01", "country": "Slovakia", "geoPoint": {"lat": 47.76356, "lon": 18.12263}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "zip": "040 01", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Levice", "zip": "934 01", "country": "Slovakia", "geoPoint": {"lat": 48.21563, "lon": 18.60705}}, {"facility": "Novartis Investigative Site", "city": "Levice", "zip": "93401", "country": "Slovakia", "geoPoint": {"lat": 48.21563, "lon": 18.60705}}, {"facility": "Novartis Investigative Site", "city": "Poprad", "zip": "058 01", "country": "Slovakia", "geoPoint": {"lat": 49.06144, "lon": 20.29798}}, {"facility": "Novartis Investigative Site", "city": "Presov", "zip": "080 01", "country": "Slovakia", "geoPoint": {"lat": 48.99839, "lon": 21.23393}}, {"facility": "Novartis Investigative Site", "city": "Spisska Nova Ves", "zip": "052 01", "country": "Slovakia", "geoPoint": {"lat": 48.94464, "lon": 20.56153}}, {"facility": "Novartis Investigative Site", "city": "Zilina", "zip": "01207", "country": "Slovakia", "geoPoint": {"lat": 49.22315, "lon": 18.73941}}, {"facility": "Novartis Investigative Site", "city": "Malaga", "state": "Andalucia", "zip": "29009", "country": "Spain", "geoPoint": {"lat": 36.72016, "lon": -4.42034}}, {"facility": "Novartis Investigative Site", "city": "Malaga", "state": "Andalucia", "zip": "29010", "country": "Spain", "geoPoint": {"lat": 36.72016, "lon": -4.42034}}, {"facility": "Novartis Investigative Site", "city": "Marbella", "state": "Andalucia", "zip": "29603", "country": "Spain", "geoPoint": {"lat": 36.51543, "lon": -4.88583}}, {"facility": "Novartis Investigative Site", "city": "Jerez", "state": "Cadiz", "zip": "11407", "country": "Spain", "geoPoint": {"lat": 36.68645, "lon": -6.13606}}, {"facility": "Novartis Investigative Site", "city": "Laredo", "state": "Cantabria", "zip": "39770", "country": "Spain", "geoPoint": {"lat": 43.4098, "lon": -3.41613}}, {"facility": "Novartis Investigative Site", "city": "Barcelona", "state": "Catalunya", "zip": "08036", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Novartis Investigative Site", "city": "Lugo", "state": "Galicia", "zip": "27003", "country": "Spain", "geoPoint": {"lat": 43.00992, "lon": -7.55602}}, {"facility": "Novartis Investigative Site", "city": "Palma de Mallorca", "state": "Islas Baleares", "zip": "07010", "country": "Spain", "geoPoint": {"lat": 39.56939, "lon": 2.65024}}, {"facility": "Novartis Investigative Site", "city": "Barcelona", "state": "Vic", "zip": "08500", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Novartis Investigative Site", "city": "Barcelona", "zip": "08006", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Novartis Investigative Site", "city": "Girona", "zip": "17005", "country": "Spain", "geoPoint": {"lat": 41.98311, "lon": 2.82493}}, {"facility": "Novartis Investigative Site", "city": "Guadalajara", "zip": "19002", "country": "Spain", "geoPoint": {"lat": 40.62862, "lon": -3.16185}}, {"facility": "Novartis Investigative Site", "city": "Madrid", "zip": "28046", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "Novartis Investigative Site", "city": "Santiago de Compostela", "zip": "15706", "country": "Spain", "geoPoint": {"lat": 42.88052, "lon": -8.54569}}, {"facility": "Novartis Investigative Site", "city": "Zaragoza", "zip": "50009", "country": "Spain", "geoPoint": {"lat": 41.65606, "lon": -0.87734}}, {"facility": "Novartis Investigative Site", "city": "Liestal", "zip": "4410", "country": "Switzerland", "geoPoint": {"lat": 47.48455, "lon": 7.73446}}, {"facility": "Novartis Investigative Site", "city": "Lugano", "zip": "6900", "country": "Switzerland", "geoPoint": {"lat": 46.01008, "lon": 8.96004}}, {"facility": "Novartis Investigative Site", "city": "Taichung", "zip": "40705", "country": "Taiwan", "geoPoint": {"lat": 24.1469, "lon": 120.6839}}, {"facility": "Novartis Investigative Site", "city": "Istanbul", "state": "TUR", "zip": "34098", "country": "Turkey", "geoPoint": {"lat": 41.01384, "lon": 28.94966}}, {"facility": "Novartis Investigative Site", "city": "Adana", "zip": "01330", "country": "Turkey", "geoPoint": {"lat": 37.00167, "lon": 35.32889}}, {"facility": "Novartis Investigative Site", "city": "Ankara", "zip": "06100", "country": "Turkey", "geoPoint": {"lat": 39.91987, "lon": 32.85427}}, {"facility": "Novartis Investigative Site", "city": "Bursa", "zip": "16059", "country": "Turkey", "geoPoint": {"lat": 40.19559, "lon": 29.06013}}, {"facility": "Novartis Investigative Site", "city": "Mersin", "zip": "33343", "country": "Turkey", "geoPoint": {"lat": 36.79526, "lon": 34.61792}}, {"facility": "Novartis Investigative Site", "city": "Yenisehir/Izmir", "zip": "35110", "country": "Turkey"}, {"facility": "Novartis Investigative Site", "city": "Cambridge", "state": "Cambrigdeshire", "zip": "CB2 0QQ", "country": "United Kingdom", "geoPoint": {"lat": 52.2, "lon": 0.11667}}, {"facility": "Novartis Investigative Site", "city": "Plymouth", "state": "Devon", "zip": "PL6 8DH", "country": "United Kingdom", "geoPoint": {"lat": 50.37153, "lon": -4.14305}}, {"facility": "Novartis Investigative Site", "city": "Chertsey", "state": "Surrey", "zip": "KT16 0PZ", "country": "United Kingdom", "geoPoint": {"lat": 51.38812, "lon": -0.50782}}, {"facility": "Novartis Investigative Site", "city": "Bradford", "state": "West Yorkshire", "zip": "BD9 6RJ", "country": "United Kingdom", "geoPoint": {"lat": 53.79391, "lon": -1.75206}}, {"facility": "Novartis Investigative Site", "city": "East Yorkshire", "zip": "HU16 5JQ", "country": "United Kingdom"}, {"facility": "Novartis Investigative Site", "city": "Leicester", "zip": "LE3 9QP", "country": "United Kingdom", "geoPoint": {"lat": 52.6386, "lon": -1.13169}}]}, "referencesModule": {"references": [{"pmid": "34895218", "type": "DERIVED", "citation": "Maspero J, Agache IO, Kamei T, Yoshida M, Boone B, Felser JM, Kawakami F, Knorr B, Lawrence D, Lehmann T, Wang W, Pedinoff AJ. Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial. Respir Res. 2021 Dec 11;22(1):311. doi: 10.1186/s12931-021-01904-8."}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.\n\nThis trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Eligible patients included patients completing a prior QAW039 Phase 3 study (CQAW039A2307, QAW039A2314, CQAW039A2316, or CQAW039A2317) and patients who had not previously participated in a QAW039 study.", "recruitmentDetails": "Participants were from ARG, AUS, AUT, BEL, BRA, BGR, CAN, CHN, COL, CZE, EST, FIN, FRA, DEU, GRC, GTM, HUN, IND, ISR, JPN, LVA, LBN, LTU, MYS, MEX, NLD, PER, PHL, POL, ROU, RUS, SAU, SRB, SGP, SVK, ESP, CHE, TWN, TUR, GBR, USA", "groups": [{"id": "FG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "FG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "FG002", "title": "Placebo", "description": "Placebo once daily"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "1093"}, {"groupId": "FG001", "numSubjects": "1085"}, {"groupId": "FG002", "numSubjects": "360"}]}, {"type": "Safety Set (SAF)", "comment": "All patients who received at least one dose of study drug during this study.", "achievements": [{"groupId": "FG000", "comment": "One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF", "numSubjects": "1092"}, {"groupId": "FG001", "comment": "One patient had no treatment administered and thus was excluded from the SAF", "numSubjects": "1084"}, {"groupId": "FG002", "comment": "One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF", "numSubjects": "361"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "76"}, {"groupId": "FG001", "numSubjects": "71"}, {"groupId": "FG002", "numSubjects": "32"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "1017"}, {"groupId": "FG001", "numSubjects": "1014"}, {"groupId": "FG002", "numSubjects": "328"}]}], "dropWithdraws": [{"type": "Study Terminated By Sponsor", "reasons": [{"groupId": "FG000", "numSubjects": "928"}, {"groupId": "FG001", "numSubjects": "938"}, {"groupId": "FG002", "numSubjects": "296"}]}, {"type": "Subject/Guardian Decision", "reasons": [{"groupId": "FG000", "numSubjects": "50"}, {"groupId": "FG001", "numSubjects": "45"}, {"groupId": "FG002", "numSubjects": "22"}]}, {"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "23"}, {"groupId": "FG001", "numSubjects": "14"}, {"groupId": "FG002", "numSubjects": "7"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "5"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "5"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Non-Compliance With Study Treatment", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Technical Problems", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "SAF: All patients who received at least one dose of study drug during this study.", "groups": [{"id": "BG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "BG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "BG002", "title": "Placebo", "description": "Placebo once daily"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "1092"}, {"groupId": "BG001", "value": "1084"}, {"groupId": "BG002", "value": "361"}, {"groupId": "BG003", "value": "2537"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "50.1", "spread": "14.95"}, {"groupId": "BG001", "value": "50.1", "spread": "15.55"}, {"groupId": "BG002", "value": "49.9", "spread": "14.99"}, {"groupId": "BG003", "value": "50.1", "spread": "15.21"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "659"}, {"groupId": "BG001", "value": "666"}, {"groupId": "BG002", "value": "229"}, {"groupId": "BG003", "value": "1554"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "433"}, {"groupId": "BG001", "value": "418"}, {"groupId": "BG002", "value": "132"}, {"groupId": "BG003", "value": "983"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Caucasian", "measurements": [{"groupId": "BG000", "value": "757"}, {"groupId": "BG001", "value": "756"}, {"groupId": "BG002", "value": "243"}, {"groupId": "BG003", "value": "1756"}]}, {"title": "Black", "measurements": [{"groupId": "BG000", "value": "30"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "11"}, {"groupId": "BG003", "value": "55"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "219"}, {"groupId": "BG001", "value": "215"}, {"groupId": "BG002", "value": "73"}, {"groupId": "BG003", "value": "507"}]}, {"title": "Native American", "measurements": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "40"}, {"groupId": "BG002", "value": "12"}, {"groupId": "BG003", "value": "79"}]}, {"title": "Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "1"}]}, {"title": "Unknown", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "11"}]}, {"title": "Other", "measurements": [{"groupId": "BG000", "value": "59"}, {"groupId": "BG001", "value": "49"}, {"groupId": "BG002", "value": "20"}, {"groupId": "BG003", "value": "128"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 52 - Cox Regression Model", "description": "Adverse events starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE) were classified as treatment emergent AEs. For this Outcome Measure, AE up to week 52 are reported.", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study. Only patients with data for all terms in the Cox regression model were included", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "52 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1081"}, {"groupId": "OG001", "value": "1077"}, {"groupId": "OG002", "value": "359"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "675"}, {"groupId": "OG001", "value": "654"}, {"groupId": "OG002", "value": "237"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Hazard Ratio = QAW039 150mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.86", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.74", "ciUpperLimit": "1.00", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Hazard Ratio = QAW039 450mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.84", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.72", "ciUpperLimit": "0.97", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Hazard Ratio = QAW039 450mg / QAW039 150mg", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.97", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.87", "ciUpperLimit": "1.09", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}]}, {"type": "PRIMARY", "title": "Number of Participants With Treatment Emergent Adverse Events (AEs) up to Week 156 - Cox Regression Model", "description": "Adverse events starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE) were classified as treatment emergent AEs", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study. Only patients with data for all terms in the Cox regression model were included", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "156 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1081"}, {"groupId": "OG001", "value": "1077"}, {"groupId": "OG002", "value": "359"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "709"}, {"groupId": "OG001", "value": "681"}, {"groupId": "OG002", "value": "243"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Hazard Ratio = QAW039 150mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.88", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.76", "ciUpperLimit": "1.02", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Hazard Ratio = QAW039 450mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.85", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.73", "ciUpperLimit": "0.99", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Hazard Ratio = QAW039 450mg / QAW039 150mg", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.97", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.86", "ciUpperLimit": "1.08", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}]}, {"type": "PRIMARY", "title": "Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 52 - Cox Regression Model", "description": "Serious Adverse events starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +30 days were classified as treatment emergent SAEs. For this Outcome Measure, AE up to week 52 are reported.", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study. Only patients with data for all terms in the Cox regression model were included", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "52 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1081"}, {"groupId": "OG001", "value": "1077"}, {"groupId": "OG002", "value": "359"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "73"}, {"groupId": "OG001", "value": "53"}, {"groupId": "OG002", "value": "29"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Hazard Ratio = QAW039 150mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.78", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.51", "ciUpperLimit": "1.22", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Hazard Ratio = QAW039 450mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.61", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.39", "ciUpperLimit": "0.97", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Hazard Ratio = QAW039 450mg / QAW039 150mg", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.78", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.54", "ciUpperLimit": "1.14", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}]}, {"type": "PRIMARY", "title": "Number of Participants With Treatment Emergent Serious Adverse Events (SAEs) up to Week 156 - Cox Regression Model", "description": "Serious Adverse events starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +30 days were classified as treatment emergent SAEs.", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study. Only patients with data for all terms in the Cox regression model were included", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "156 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1081"}, {"groupId": "OG001", "value": "1077"}, {"groupId": "OG002", "value": "359"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "86"}, {"groupId": "OG001", "value": "63"}, {"groupId": "OG002", "value": "33"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Hazard Ratio = QAW039 150mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.80", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.54", "ciUpperLimit": "1.22", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Hazard Ratio = QAW039 450mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.63", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.41", "ciUpperLimit": "0.97", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Hazard Ratio = QAW039 450mg / QAW039 150mg", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.78", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.55", "ciUpperLimit": "1.11", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}]}, {"type": "PRIMARY", "title": "Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 52 - Cox Regression Model", "description": "Adverse events leading to study treatment discontinuation starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE) were classified as treatment emergent AEs leading to study treatment discontinuation. For this Outcome Measure, AE up to week 52 are reported.", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study. Only patients with data for all terms in the Cox regression model were included", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "52 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1081"}, {"groupId": "OG001", "value": "1077"}, {"groupId": "OG002", "value": "359"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "26"}, {"groupId": "OG001", "value": "33"}, {"groupId": "OG002", "value": "9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Hazard Ratio = QAW039 150mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "0.98", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.47", "ciUpperLimit": "2.23", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Hazard Ratio = QAW039 450mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "1.18", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.59", "ciUpperLimit": "2.64", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Hazard Ratio = QAW039 450mg / QAW039 150mg", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "1.20", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.70", "ciUpperLimit": "2.10", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}]}, {"type": "PRIMARY", "title": "Number of Participants With Treatment Emergent AEs Leading to Discontinuation From Study Treatment up to Week 156 - Cox Regression Model", "description": "Adverse events leading to study treatment discontinuation starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE) were classified as treatment emergent AEs leading to study treatment discontinuation", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study. Only patients with data for all terms in the Cox regression model were included.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "156 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1081"}, {"groupId": "OG001", "value": "1077"}, {"groupId": "OG002", "value": "359"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "37"}, {"groupId": "OG002", "value": "9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Hazard Ratio = QAW039 150mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "1.14", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.56", "ciUpperLimit": "2.56", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Hazard Ratio = QAW039 450mg / Placebo", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "1.33", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.67", "ciUpperLimit": "2.95", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Hazard Ratio = QAW039 450mg / QAW039 150mg", "nonInferiorityType": "OTHER", "statisticalMethod": "Regression, Cox", "statisticalComment": "The Cox regression model = treatment group+ severity of asthma + region as fixed class effects, stratified by randomization stratum", "paramType": "Hazard Ratio (HR)", "paramValue": "1.17", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.70", "ciUpperLimit": "1.96", "estimateComment": "A hazard ratio \\< 1 favors the treatment group in the numerator of the ratio."}]}, {"type": "SECONDARY", "title": "Number of Patients With at Least One Treatment Emergent AE by Primary System Organ Class up to Week 52 - Logistic Regression Model", "description": "The number of patients per patient year of follow-up having a treatment emergent adverse event, categorized by system organ class. Treatment emergent adverse events are defined as an AEs starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE)", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study. Only patients with data for all terms in the Logistic regression model were included", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "52 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1081"}, {"groupId": "OG001", "value": "1077"}, {"groupId": "OG002", "value": "359"}]}], "classes": [{"title": "Number of patients with at least one AE", "categories": [{"measurements": [{"groupId": "OG000", "value": "675"}, {"groupId": "OG001", "value": "654"}, {"groupId": "OG002", "value": "237"}]}]}, {"title": "Blood and lymphatic system disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "21"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "5"}]}]}, {"title": "Cardiac disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "26"}, {"groupId": "OG002", "value": "7"}]}]}, {"title": "Congenital, familial and genetic disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "3"}, {"groupId": "OG002", "value": "0"}]}]}, {"title": "Ear and labyrinth disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "8"}]}]}, {"title": "Endocrine disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "0"}]}]}, {"title": "Eye disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "11"}, {"groupId": "OG002", "value": "9"}]}]}, {"title": "Gastrointestinal disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "88"}, {"groupId": "OG001", "value": "86"}, {"groupId": "OG002", "value": "32"}]}]}, {"title": "General disorders & administration site conditions", "categories": [{"measurements": [{"groupId": "OG000", "value": "38"}, {"groupId": "OG001", "value": "33"}, {"groupId": "OG002", "value": "7"}]}]}, {"title": "Hepatobiliary disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "9"}, {"groupId": "OG001", "value": "17"}, {"groupId": "OG002", "value": "7"}]}]}, {"title": "Immune system disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "6"}]}]}, {"title": "Infections and infestations", "categories": [{"measurements": [{"groupId": "OG000", "value": "400"}, {"groupId": "OG001", "value": "374"}, {"groupId": "OG002", "value": "145"}]}]}, {"title": "Injury, poisoning and procedural complications", "categories": [{"measurements": [{"groupId": "OG000", "value": "67"}, {"groupId": "OG001", "value": "52"}, {"groupId": "OG002", "value": "23"}]}]}, {"title": "Investigations", "categories": [{"measurements": [{"groupId": "OG000", "value": "79"}, {"groupId": "OG001", "value": "85"}, {"groupId": "OG002", "value": "20"}]}]}, {"title": "Metabolism and nutrition disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "53"}, {"groupId": "OG001", "value": "50"}, {"groupId": "OG002", "value": "21"}]}]}, {"title": "Musculoskeletal and connective tissue disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "91"}, {"groupId": "OG001", "value": "84"}, {"groupId": "OG002", "value": "24"}]}]}, {"title": "Neoplasms benign, malignant and unspecified", "categories": [{"measurements": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "3"}]}]}, {"title": "Nervous system disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "67"}, {"groupId": "OG001", "value": "73"}, {"groupId": "OG002", "value": "29"}]}]}, {"title": "Product issues", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}]}]}, {"title": "Psychiatric disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "15"}, {"groupId": "OG002", "value": "9"}]}]}, {"title": "Renal and urinary disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "41"}, {"groupId": "OG002", "value": "8"}]}]}, {"title": "Reproductive system and breast disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "4"}]}]}, {"title": "Respiratory, thoracic and mediastinal disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "308"}, {"groupId": "OG001", "value": "304"}, {"groupId": "OG002", "value": "135"}]}]}, {"title": "Skin and subcutaneous tissue disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "38"}, {"groupId": "OG001", "value": "39"}, {"groupId": "OG002", "value": "13"}]}]}, {"title": "Social circumstances", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "3"}]}]}, {"title": "Vascular disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "33"}, {"groupId": "OG002", "value": "9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Statistical Analysis for Number of patients with at least one AE. Hazard Ratio = QAW039 150mg /Placebo", "nonInferiorityType": "SUPERIORITY", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic regression model: logit (proportion) = randomization stratum, treatment, severity of asthma, region as fixed effects", "paramType": "Odds Ratio (OR)", "paramValue": "0.81", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.626", "ciUpperLimit": "1.047"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Statistical Analysis for Number of patients with at least one AE. Hazard Ratio = QAW039 450mg /Placebo", "nonInferiorityType": "SUPERIORITY", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic regression model: logit (proportion) = randomization stratum, treatment, severity of asthma, region as fixed effects", "paramType": "Odds Ratio (OR)", "paramValue": "0.80", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.622", "ciUpperLimit": "1.038"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Statistical Analysis for Number of patients with at least one AE. Hazard Ratio = QAW039 450mg /QAW039 150mg", "nonInferiorityType": "SUPERIORITY", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic regression model: logit (proportion) = randomization stratum, treatment, severity of asthma, region as fixed effects", "paramType": "Odds Ratio (OR)", "paramValue": "0.99", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.821", "ciUpperLimit": "1.200"}]}, {"type": "SECONDARY", "title": "Number of Patients With at Least One Treatment Emergent AE by Primary System Organ Class up to Week 156 - Logistic Regression Model", "description": "The number of patients per patient year of follow-up having a treatment emergent adverse event, categorized by system organ class. Treatment emergent adverse events are defined as an AEs starting on or after the day of the first intake of study drug in this study and until the day of last intake of study drug +7 days (30 days in the case of a serious AE)", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study. Only patients with data for all terms in the Logistic regression model were included.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "156 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1081"}, {"groupId": "OG001", "value": "1077"}, {"groupId": "OG002", "value": "359"}]}], "classes": [{"title": "Number of patients with at least one AE", "categories": [{"measurements": [{"groupId": "OG000", "value": "710"}, {"groupId": "OG001", "value": "682"}, {"groupId": "OG002", "value": "243"}]}]}, {"title": "Blood and lymphatic system disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "12"}, {"groupId": "OG002", "value": "5"}]}]}, {"title": "Cardiac disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "34"}, {"groupId": "OG002", "value": "7"}]}]}, {"title": "Congenital, familial and genetic disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "3"}, {"groupId": "OG002", "value": "1"}]}]}, {"title": "Ear and labyrinth disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "13"}, {"groupId": "OG002", "value": "9"}]}]}, {"title": "Endocrine disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "7"}, {"groupId": "OG002", "value": "0"}]}]}, {"title": "Eye disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "16"}, {"groupId": "OG001", "value": "14"}, {"groupId": "OG002", "value": "9"}]}]}, {"title": "Gastrointestinal disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "101"}, {"groupId": "OG001", "value": "96"}, {"groupId": "OG002", "value": "38"}]}]}, {"title": "General disorders & administration site conditions", "categories": [{"measurements": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "34"}, {"groupId": "OG002", "value": "8"}]}]}, {"title": "Hepatobiliary disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "21"}, {"groupId": "OG002", "value": "8"}]}]}, {"title": "Immune system disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "11"}, {"groupId": "OG002", "value": "6"}]}]}, {"title": "Infections and infestations", "categories": [{"measurements": [{"groupId": "OG000", "value": "436"}, {"groupId": "OG001", "value": "415"}, {"groupId": "OG002", "value": "151"}]}]}, {"title": "Injury, poisoning and procedural complications", "categories": [{"measurements": [{"groupId": "OG000", "value": "80"}, {"groupId": "OG001", "value": "63"}, {"groupId": "OG002", "value": "28"}]}]}, {"title": "Investigations", "categories": [{"measurements": [{"groupId": "OG000", "value": "90"}, {"groupId": "OG001", "value": "102"}, {"groupId": "OG002", "value": "24"}]}]}, {"title": "Metabolism and nutrition disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "61"}, {"groupId": "OG001", "value": "60"}, {"groupId": "OG002", "value": "23"}]}]}, {"title": "Musculoskeletal and connective tissue disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "102"}, {"groupId": "OG001", "value": "92"}, {"groupId": "OG002", "value": "31"}]}]}, {"title": "Neoplasms benign, malignant and unspecified", "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "11"}, {"groupId": "OG002", "value": "3"}]}]}, {"title": "Nervous system disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "83"}, {"groupId": "OG001", "value": "77"}, {"groupId": "OG002", "value": "32"}]}]}, {"title": "Pregnancy, puerperium and perinatal conditions", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}]}]}, {"title": "Product issues", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}]}]}, {"title": "Psychiatric disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "18"}, {"groupId": "OG002", "value": "9"}]}]}, {"title": "Renal and urinary disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "36"}, {"groupId": "OG001", "value": "45"}, {"groupId": "OG002", "value": "10"}]}]}, {"title": "Reproductive system and breast disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "10"}, {"groupId": "OG002", "value": "4"}]}]}, {"title": "Respiratory, thoracic and mediastinal disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "336"}, {"groupId": "OG001", "value": "341"}, {"groupId": "OG002", "value": "144"}]}]}, {"title": "Skin and subcutaneous tissue disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "45"}, {"groupId": "OG002", "value": "15"}]}]}, {"title": "Social circumstances", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "3"}]}]}, {"title": "Vascular disorders", "categories": [{"measurements": [{"groupId": "OG000", "value": "45"}, {"groupId": "OG001", "value": "40"}, {"groupId": "OG002", "value": "13"}]}]}], "analyses": [{"groupIds": ["OG000", "OG002"], "groupDescription": "Statistical Analysis for Number of patients with at least one AE. Hazard Ratio = QAW039 150mg /Placebo", "nonInferiorityType": "SUPERIORITY", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic regression model: logit (proportion) = randomization stratum, treatment, severity of asthma, region as fixed effects", "paramType": "Odds Ratio (OR)", "paramValue": "0.87", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.667", "ciUpperLimit": "1.125"}, {"groupIds": ["OG001", "OG002"], "groupDescription": "Statistical Analysis for Number of patients with at least one AE. Hazard Ratio = QAW039 450mg /Placebo", "nonInferiorityType": "SUPERIORITY", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic regression model: logit (proportion) = randomization stratum, treatment, severity of asthma, region as fixed effects", "paramType": "Odds Ratio (OR)", "paramValue": "0.83", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.643", "ciUpperLimit": "1.082"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Statistical Analysis for Number of patients with at least one AE. Hazard Ratio = QAW039 450mg /QAW039 150mg", "nonInferiorityType": "SUPERIORITY", "statisticalMethod": "Regression, Logistic", "statisticalComment": "Logistic regression model: logit (proportion) = randomization stratum, treatment, severity of asthma, region as fixed effects", "paramType": "Odds Ratio (OR)", "paramValue": "0.96", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.794", "ciUpperLimit": "1.167"}]}, {"type": "SECONDARY", "title": "Number of Treatment Emergent Patient Deaths Due to an Asthma Exacerbation up to Week 52", "description": "The number of treatment emergent patient deaths due to an asthma exacerbation. Treatment emergent deaths are defined as deaths resulting from treatment emergent AEs.", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Number of deaths", "timeFrame": "52 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1092"}, {"groupId": "OG001", "value": "1084"}, {"groupId": "OG002", "value": "361"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Number of Treatment Emergent Patient Deaths Due to an Asthma Exacerbation up to Week 156", "description": "The number of treatment emergent patient deaths due to an asthma exacerbation. Treatment emergent deaths are defined as deaths resulting from treatment emergent AEs.", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Number of deaths", "timeFrame": "156 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1092"}, {"groupId": "OG001", "value": "1084"}, {"groupId": "OG002", "value": "361"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Rate of Treatment Emergent Severe Asthma Exacerbation Episodes Requiring Hospitalizations Per Person Year up to Week 52", "description": "Number of treatment emergent severe asthma exacerbation episodes requiring hospitalizations (any visit to the hospital requiring an overnight stay or an emergency room visit greater than 24 hours) per person year of follow-up. Treatment emergent severe asthma exacerbation episodes are defined as episodes occurring on or after the day of the first intake of study drug and until the day of last intake of study drug +7 days (30 days in the case of a serious AE).\n\nRate of exacerbations per person year = total number of exacerbations / total number of treatment years", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Hospitalizations per person year", "timeFrame": "52 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1092"}, {"groupId": "OG001", "value": "1084"}, {"groupId": "OG002", "value": "361"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.04"}, {"groupId": "OG001", "value": "0.02"}, {"groupId": "OG002", "value": "0.06"}]}]}]}, {"type": "SECONDARY", "title": "Rate of Treatment Emergent Severe Asthma Exacerbation Episodes Requiring Hospitalizations Per Person Year up to Week 156", "description": "Number of treatment emergent severe asthma exacerbation episodes requiring hospitalizations (any visit to the hospital requiring an overnight stay or an emergency room visit greater than 24 hours) per person year of follow-up. Treatment emergent severe asthma exacerbation episodes are defined as episodes occurring on or after the day of the first intake of study drug and until the day of last intake of study drug +7 days (30 days in the case of a serious AE).\n\nRate of exacerbations per person year = total number of exacerbations / total number of treatment years", "populationDescription": "Safety analysis set (SAF): included all patients who received at least one dose of study drug during this study. Patients were analyzed according to the treatment they received during this study.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Hospitalizations per person year", "timeFrame": "156 weeks", "groups": [{"id": "OG000", "title": "QAW039 150mg", "description": "QAW039 Dose 1 once daily"}, {"id": "OG001", "title": "QAW039 450 mg", "description": "QAW039 Dose 2 once daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo once daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1092"}, {"groupId": "OG001", "value": "1084"}, {"groupId": "OG002", "value": "361"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.04"}, {"groupId": "OG001", "value": "0.02"}, {"groupId": "OG002", "value": "0.05"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "2", "timeFrame": "Adverse events were collected from first dose of study treatment until end of study treatment plus 7 days post treatment (30 days in the case of a serious AE), up to maximum duration of 156 weeks.", "description": "Any sign or symptom that occurs during the study treatment plus the 7 days post treatment (30 days in the case of a serious AE).", "eventGroups": [{"id": "EG000", "title": "QAW039 150 mg", "description": "QAW039 150 mg", "deathsNumAffected": 3, "deathsNumAtRisk": 1092, "seriousNumAffected": 87, "seriousNumAtRisk": 1092, "otherNumAffected": 525, "otherNumAtRisk": 1092}, {"id": "EG001", "title": "QAW039 450 mg", "description": "QAW039 450 mg", "deathsNumAffected": 1, "deathsNumAtRisk": 1084, "seriousNumAffected": 64, "seriousNumAtRisk": 1084, "otherNumAffected": 499, "otherNumAtRisk": 1084}, {"id": "EG002", "title": "Placebo", "description": "Placebo", "deathsNumAffected": 1, "deathsNumAtRisk": 361, "seriousNumAffected": 33, "seriousNumAtRisk": 361, "otherNumAffected": 190, "otherNumAtRisk": 361}], "seriousEvents": [{"term": "Blood loss anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Arteriosclerosis coronary artery", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Mitral valve incompetence", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Pericardial effusion", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Ventricular extrasystoles", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Fibrous dysplasia of bone", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Skeletal dysplasia", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Meniere's disease", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Tympanic membrane perforation", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Vertigo", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Abdominal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Dyspepsia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Haemorrhoids", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Intestinal obstruction", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Large intestinal obstruction", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Melaena", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Pancreatitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Pancreatitis acute", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 361}]}, {"term": "Peritoneal cyst", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Peritoneal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Strangulated umbilical hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Hyperplasia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Swelling face", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Eosinophilic granulomatosis with polyangiitis", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Acute sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Bacterial infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Bronchitis bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Chronic sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Dengue fever", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Dengue haemorrhagic fever", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Diverticulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Lung abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Otitis media", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 361}]}, {"term": "Pneumonia bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Pyelonephritis acute", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Rectal abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Septic shock", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Tuberculosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Upper respiratory tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Urosepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Vaginal abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Viral upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Ankle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Exposure to allergen", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Fall", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Femur fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Foot fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Fracture displacement", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Humerus fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Joint injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Lumbar vertebral fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Multiple injuries", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Radius fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Rib fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Road traffic accident", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Skeletal injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Upper limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Wrist fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Electrocardiogram Q wave abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Electrocardiogram T wave inversion", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Oxygen saturation decreased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Diabetes mellitus inadequate control", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Hyperlipidaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Arthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Intervertebral disc degeneration", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Intervertebral disc protrusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Muscular weakness", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Adenocarcinoma of colon", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Basal cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Breast cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Cervix carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Gastric cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Intraductal proliferative breast lesion", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Lung neoplasm malignant", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Malignant melanoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Myeloproliferative neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Prostate cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Rectal neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Renal cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Tongue neoplasm malignant stage unspecified", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Transitional cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Uterine leiomyoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Brain stem haemorrhage", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Cerebral infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Cerebral ischaemia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Colloid brain cyst", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Dyspraxia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Facial paralysis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Guillain-Barre syndrome", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Ischaemic stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 361}]}, {"term": "Loss of consciousness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Lumbar radiculopathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Pregnancy", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Acute kidney injury", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Calculus urinary", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Chronic kidney disease", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Nephrolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Ureterolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Endometrial hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Uterine polyp", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Aphonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 30, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 16, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 13, "numAtRisk": 361}]}, {"term": "Diaphragmatic paralysis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 361}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Pulmonary mass", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Wheezing", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Aortic stenosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Deep vein thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 361}]}], "otherEvents": [{"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 75, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 55, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 38, "numAtRisk": 361}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 30, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 28, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 361}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 110, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 106, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 36, "numAtRisk": 361}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 34, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 22, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 15, "numAtRisk": 361}]}, {"term": "Sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 39, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 28, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 361}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 72, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 43, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 25, "numAtRisk": 361}]}, {"term": "Upper respiratory tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 14, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 31, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 12, "numAtRisk": 361}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 23, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 37, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 11, "numAtRisk": 361}]}, {"term": "Viral upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 34, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 31, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 9, "numAtRisk": 361}]}, {"term": "Blood creatinine increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 30, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 42, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 361}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 22, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 11, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 8, "numAtRisk": 361}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 29, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 31, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 361}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 41, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 29, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 24, "numAtRisk": 361}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 291, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 275, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 125, "numAtRisk": 361}]}, {"term": "Rhinitis allergic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 19, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 28, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 11, "numAtRisk": 361}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (22.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 30, "numAtRisk": 1092}, {"groupId": "EG001", "numAffected": 30, "numAtRisk": 1084}, {"groupId": "EG002", "numAffected": 11, "numAtRisk": 361}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."}, "pointOfContact": {"title": "Study Director", "organization": "Novartis Pharmaceuticals", "email": "novartis.email@novartis.com", "phone": "862-778-8300"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2020-03-21", "uploadDate": "2020-09-14T03:50", "filename": "SAP_000.pdf", "size": 485617}, {"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2018-01-17", "uploadDate": "2020-09-14T03:50", "filename": "Prot_001.pdf", "size": 1028054}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M7591", "name": "Dyspnea", "relevance": "LOW"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000007210", "term": "Indoleacetic Acids"}], "ancestors": [{"id": "D000010937", "term": "Plant Growth Regulators"}, {"id": "D000006133", "term": "Growth Substances"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M10254", "name": "Indoleacetic Acids", "asFound": "Renal Dysfunction", "relevance": "HIGH"}], "browseBranches": [{"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}